RT Journal Article
SR Electronic
T1 Correction: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e0796-5corr1
DO 10.1136/jitc-2020-0796-5corr1
VO 8
IS 1
YR 2020
UL http://jitc.bmj.com/content/8/1/e0796-5corr1.abstract